Advanced Therapeutics Pharmaceutical Outsourcing Market Forecast Showing Industry Progress And Growth Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Advanced Therapeutics Pharmaceutical Outsourcing Market Between 2026 And 2030?
The advanced therapeutics pharmaceutical outsourcing market has experienced consistent expansion in recent years. Its size is anticipated to expand from $8.41 billion in 2025 to $8.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.0%. The historical growth of this market can be linked to factors such as an expanding biologics pipeline, the substantial costs involved in in-house manufacturing, a rising incidence of oncology and rare diseases, an absence of internal expertise in advanced therapies, and the increasing globalization of clinical trials.
The advanced therapeutics pharmaceutical outsourcing market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $10.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth can be attributed to several factors such as the increasing adoption of personalized medicine, the expansion of commercial-scale cell and gene therapies, an escalation in regulatory complexity, a surge in funding for biotech start-ups, and the imperative for a faster time-to-market. During the forecast period, significant trends are expected to include a rise in the outsourcing of cell and gene therapy manufacturing, growing demand for end-to-end CDMO services, the development of specialized viral vector production capabilities, an intensified focus on regulatory and quality compliance assistance, and accelerated clinical trial outsourcing for rare and complex medical conditions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What Primary Drivers Are Shaping The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The growing adoption of cell and gene therapies is anticipated to fuel the expansion of the advanced therapeutics pharmaceutical outsourcing market. These therapies represent innovative treatments that utilize living cells or genetic material to address or cure diseases. Advanced therapeutics pharmaceutical outsourcing supports cell and gene therapies by connecting companies with providers possessing proven expertise and experienced personnel, thereby saving time and resources that would otherwise be spent on developing internal teams. For instance, in March 2024, IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, disclosed that global spending on cell and gene therapies reached $5.9 billion in 2023, which was a 38% increase from 2022. Hence, the increasing integration of cell and gene therapies is a key driver for the growth of the advanced therapeutics pharmaceutical outsourcing market.
How Is The Advanced Therapeutics Pharmaceutical Outsourcing Market Organized By Segment Classification?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
What Emerging Trends Are Seen In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Key players in the advanced therapeutics pharmaceutical outsourcing market are prioritizing strategic partnerships to offer reliable services to their customers. A strategic partnership represents a collaborative arrangement between two or more organizations, typically businesses, designed to achieve mutually beneficial goals that each partner could not accomplish on their own. For instance, in January 2023, Lonza, a manufacturing company from Switzerland active in the pharmaceutical, biotechnology, and nutrition sectors, formed a partnership with Context Therapeutics Inc., a US-based biopharmaceutical firm dedicated to advancing medicines for solid tumors. This collaboration involves Lonza providing services such as manufacturability assessment, gene and cell line construction, and process development for both the drug substance and drug product.
Who Are The Industry Participants Involved In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
Get The Full Advanced Therapeutics Pharmaceutical Outsourcing Market Report:
Which Region Accounts For The Largest Portion Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Advanced Therapeutics Pharmaceutical Outsourcing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Advanced Therapeutics Pharmaceutical Outsourcing Market 2026, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Pharmaceutical Fill And Finish Outsourcing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
